Lv31
320 积分 2025-06-21 加入
AT1, a small molecular degrader of BRD4 based on proteolysis targeting chimera technology alleviates renal fibrosis and inflammation in diabetic nephropathy
1分钟前
待确认
BRD4-targeting PROTACs Synergize With Chemotherapeutics Against Osteosarcoma Cell Lines
7分钟前
求助中
BRD4-targeting PROTACs Synergize With Chemotherapeutics Against Osteosarcoma Cell Lines
10分钟前
已关闭
BRD4 inhibitor MZ1 exerts anti-cancer effects by targeting MYCN and MAPK signaling in neuroblastoma
17分钟前
已完结
BRD4 PROTAC as a novel therapeutic approach for the treatment of vemurafenib resistant melanoma: Preformulation studies, formulation development and in vitro evaluation
18分钟前
已完结
Selective degradation of BET proteins with dBET1, a proteolysis-targeting chimera, potently reduces pro-inflammatory responses in lipopolysaccharide-activated microglia
34分钟前
已完结
Brd4 proteolysis-targeting chimera nanoparticles sensitized colorectal cancer chemotherapy
37分钟前
已完结
Selective degradation of cellular BRD3 and BRD4-L promoted by PROTAC molecules in six cancer cell lines
1小时前
已完结
BRD4 PROTAC degrader MZ1 exhibits anti-B-cell acute lymphoblastic leukemia effects via targeting CCND3
1小时前
已完结
Liver-targeting chimeras as a potential modality for the treatment of liver diseases
1小时前
已完结
皖公网安备34019202002308
